Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Cosmos Health (COSM) Non Operating Income (2016 - 2025)

Cosmos Health's Non Operating Income history spans 10 years, with the latest figure at $115904.0 for Q4 2025.

  • Quarterly results put Non Operating Income at $115904.0 for Q4 2025, up 87.13% from a year ago — trailing twelve months through Dec 2025 was -$3.7 million (down 6092.57% YoY), and the annual figure for FY2023 was -$65867.0, up 97.28%.
  • Non Operating Income for Q4 2025 was $115904.0 at Cosmos Health, up from -$3.5 million in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $2.3 million in Q4 2021 to a low of -$3.5 million in Q3 2025.
  • The 5-year median for Non Operating Income is -$78411.0 (2024), against an average of -$509432.8.
  • The sharpest move saw Non Operating Income skyrocketed 359.51% in 2021, then plummeted 183875.79% in 2025.
  • Year by year, Non Operating Income stood at $2.3 million in 2021, then crashed by 102.75% to -$63485.0 in 2022, then tumbled by 5444.94% to -$3.5 million in 2023, then soared by 101.76% to $61937.0 in 2024, then surged by 87.13% to $115904.0 in 2025.
  • According to Business Quant data, Non Operating Income over the past three periods came in at $115904.0, -$3.5 million, and -$182749.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.